Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDMENT TO FORM 8-K - RIGHTNOW TECHNOLOGIES INC | c54395e8vkza.htm |
| EX-99.4 - EX-99.4 - RIGHTNOW TECHNOLOGIES INC | c54395exv99w4.htm |
| EX-99.2 - EX-99.2 - RIGHTNOW TECHNOLOGIES INC | c54395exv99w2.htm |
| EX-23.1 - EX-23.1 - RIGHTNOW TECHNOLOGIES INC | c54395exv23w1.htm |
| EX-23.2 - EX-23.2 - RIGHTNOW TECHNOLOGIES INC | c54395exv23w2.htm |
Exhibit 99.3
HiveLive, Inc.
(a development stage company)
Statements of Operations
(unaudited)
(a development stage company)
Statements of Operations
(unaudited)
| Six Months Ended June 30, |
||||||||
| 2009 | 2008 | |||||||
Revenues |
$ | 553,079 | $ | 195,525 | ||||
Operating expenses |
||||||||
Sales and marketing |
1,300,329 | 721,262 | ||||||
Direct costs and expenses |
73,061 | 31,843 | ||||||
Product development |
523,579 | 335,027 | ||||||
General and administrative |
647,761 | 367,975 | ||||||
Total operating expenses |
2,544,730 | 1,456,107 | ||||||
Loss from operations |
(1,991,651 | ) | (1,260,582 | ) | ||||
Other income (expense) |
||||||||
Interest income |
12,827 | 140 | ||||||
Interest expense |
(20,656 | ) | (410 | ) | ||||
Total other income |
(7,829 | ) | (270 | ) | ||||
Net loss |
$ | (1,999,480 | ) | $ | (1,260,852 | ) | ||
HiveLive, Inc.
(a development stage company)
BALANCE SHEET
(unaudited)
(a development stage company)
BALANCE SHEET
(unaudited)
| June 30 | ||||
| 2009 | ||||
Assets |
||||
Current assets |
||||
Cash and cash equivalents |
1,201,287 | |||
Restricted cash |
50,000 | |||
Accounts receivable, net |
255,178 | |||
Deferred direct costs of revenue |
139,193 | |||
Other assets |
39,485 | |||
Total current assets |
1,685,143 | |||
Non-current assets |
||||
Property and equipment, net |
194,307 | |||
Deferred direct costs of revenue, net of current portion |
76,943 | |||
Deposits |
23,907 | |||
Total non-current assets |
295,157 | |||
Total assets |
1,980,300 | |||
Liabilities & Stockholders’ Equity |
||||
Current liabilities |
||||
Accounts payable and accrued liabilities |
64,741 | |||
Deferred revenue |
490,477 | |||
Current portion of long-term debt |
989,093 | |||
Total current liabilities |
1,544,311 | |||
Non-current liabilities |
||||
Long-term debt, net of current portion |
— | |||
Total Liabilities |
1,544,311 | |||
Stockholders’ equity |
||||
Preferred Series A stock, $0.001 par value. Authorized
13,392,034 and 20,528,948 shares; 13,241,920 shares
issued and outstanding as of June 30, 2009 and 2008,
respectively |
2,171,984 | |||
Preferred Series B stock, $0.001 par value. Authorized
17,009,495 shares issued and outstanding as of June 30,
2009 and 2008 respectively |
5,526,617 | |||
Common stock, $0.001 par value. Authorized 50,000,000
and 11,782,250 shares; 9,076,500 shares issued and
outstanding at June 30, 2009 and 2008, respectively |
11,782 | |||
Additional paid-in capital |
51,683 | |||
Deficit accumulated during the development stage |
(7,326,077 | ) | ||
Total stockholders’ equity |
435,989 | |||
Total liabilities & stockholder’s equity |
1,980,300 | |||
HiveLive, Inc.
(a development stage company)
Statements of Cash Flows
(unaudited)
(a development stage company)
Statements of Cash Flows
(unaudited)
| Six Months Ended June 30, |
||||||||
| 2009 | 2008 | |||||||
Cash flows from operating activities |
||||||||
Net loss |
(1,999,480 | ) | (1,260,852 | ) | ||||
Adjustments to reconcile net loss to net cash
used in operating activities |
||||||||
Depreciation expense |
40,646 | 14,138 | ||||||
Common stock issued for services |
— | — | ||||||
Stock-based compensation |
— | — | ||||||
Value of warrants issued upon debt conversion |
— | — | ||||||
Amortization of debt discount |
— | — | ||||||
Changes in operating assets and liabilities |
||||||||
Accounts receivable |
(129,770 | ) | (97,252 | ) | ||||
Prepaid commissions |
4,981 | — | ||||||
Other assets |
18,190 | (24,562 | ) | |||||
Deposits |
— | (6,977 | ) | |||||
Accounts payable and accrued liabilities |
(107,850 | ) | (20,834 | ) | ||||
Deferred revenue |
261,476 | 39,100 | ||||||
Net cash used in operating activities |
(1,911,807 | ) | (1,357,239 | ) | ||||
Cash flows from investing activities |
||||||||
Purchase of property & equipment |
(14,031 | ) | (90,303 | ) | ||||
Restricted cash |
— | — | ||||||
Net cash used in investing activities |
(14,031 | ) | (90,303 | ) | ||||
Cash flows from financing activities |
||||||||
Proceeds from issuance of preferred stock |
— | 5,615,724 | ||||||
Equity offering costs |
— | |||||||
Proceeds from convertible note payable |
— | — | ||||||
Proceeds from the issuance of common stock |
10,890 | — | ||||||
Net cash provided by financing activities |
10,890 | 5,615,724 | ||||||
Net increase (decrease) in cash and cash equivalents |
(1,914,948 | ) | 4,168,182 | |||||
Cash and cash equivalents — beginning of period |
3,116,235 | 491,454 | ||||||
Cash and cash equivalents — end of period |
1,201,287 | 4,659,636 | ||||||